Board to consider Final Dividend
Aventis Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 16, 2011, for approving the audited Accounts for the year ended December 31, 2010 and also to consider recommendation of final Dividend for the said financial year. Publish Audited Results
Aventis Pharma Ltd has informed BSE that the Company will not publish the Unaudited Financial Results for the quarter ended December 31, 2010 and undertakes to publish the Audited Results for the year ended December 31, 2010 before February 28, 2011. Updates on Sale of 49% shareholding in Chiron Behring Vaccines Private Limited
With reference to the earlier announcement dated December 13, 2010 regarding decision taken to sell 49% shareholding in Chiron Behring Vaccines Private Limited (CBVPL), Aventis Pharma Ltd now has informed BSE that the sale of the shareholding was completed on December 23, 2010, being the date of closing.The Company received sale consideration of Rs. 1007.5 million (equivalent to US Dollars 22.399 million).... Sale of 49% shareholding in Chiron Behring Vaccines Pvt. Ltd.
Aventis Pharma Ltd has informed BSE regarding "Sale of 49% shareholding in Chiron Behring Vaccines Pvt. Ltd."Announcement :"We are holding 4,900,000 shares in Chiron Behring Vaccines Private Limited (CBVPL) representing 49% of the paid up capital CBVPL. The balance 51% shares are held by our joint venture partner, Novartis Vaccines & Diagnostics Inc. CBVPL manufactures the anti-rabies vaccine Rabipur at its plant in Ankleshwar, which... Sanofi-aventis launches 'I Am A Champ' program to celebrate diabetes control
Aventis Pharma Ltd has informed BSE regarding a Press Release dated November 29, 2010, titled "Sanofi-aventis launches 'I Am A Champ' program to celebrate diabetes control"Press Release:"The I Am A champ program for Diabetes Control was launched by Dr. Shailesh Ayyangar, Managing Director, Aventis Pharma Ltd (sanofi-aventis Group) India, at the I Am A champ awards ceremony today.... Change in Directorate
Aventis Pharma Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on October 25, 2010 the Board of Directors has appointed Mr. M G Rao and Mr. S C Ghoge as Alternates to Mr. J M Georges and Mr. F X Duhalde, respectively. Financial Results for Sep 30, 2010
Aventis Pharma Ltd has informed BSE about the Financial Results for the Quarter ended September 30, 2010. Appointment of Directors
Aventis Pharma Ltd has informed BSE about the following changes which have taken place in the Board of Directors of the Company:1. Mr. M. Dargentolle, Chief Financial Officer of the Company who was Alternate Director to Mr. O. Charmeil has been appointed a Director of the Company with effect from July 19, 2010.2. Mr. J. M. Georges, Director, Industrial Pharma Intercontinental of the sanofi-aventis Group and Mr. F. X. Duhalde, Director... Financial Results for Jun 30, 2010
Aventis Pharma Ltd has informed BSE about the Financial Results for the Quarter ended June 30, 2010. Board declares Interim Dividend
Aventis Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 19, 2010, inter alia, has declared an Interim Dividend of Rs. 4 per Equity Share of Rs. 10.